361 related articles for article (PubMed ID: 21619683)
1. Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein.
Ma Q; Guin S; Padhye SS; Zhou YQ; Zhang RW; Wang MH
Mol Cancer; 2011 May; 10():66. PubMed ID: 21619683
[TBL] [Abstract][Full Text] [Related]
2. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
Wang D; Shen Q; Chen YQ; Wang MH
Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of RON-mediated epithelial-mesenchymal transition in MDCK cells through the MAPK pathway.
Xiangming X; Yun Q; Guoliang Z; Jianjiang L; Lisong T
Braz J Med Biol Res; 2011 Jul; 44(7):634-41. PubMed ID: 21655705
[TBL] [Abstract][Full Text] [Related]
4. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
[TBL] [Abstract][Full Text] [Related]
5. The MSP-RON pathway regulates liver fibrosis through transforming growth factor beta-dependent epithelial-mesenchymal transition.
Weng T; Yan D; Shi D; Zhu M; Liu Y; Wu Z; Tang T; Zhu L; Zhang H; Yao H; Li L
Liver Int; 2021 Aug; 41(8):1956-1968. PubMed ID: 33786995
[TBL] [Abstract][Full Text] [Related]
6. Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein.
Wang MH; Montero-Julian FA; Dauny I; Leonard EJ
Oncogene; 1996 Nov; 13(10):2167-75. PubMed ID: 8950984
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member.
O'Toole JM; Rabenau KE; Burns K; Lu D; Mangalampalli V; Balderes P; Covino N; Bassi R; Prewett M; Gottfredsen KJ; Thobe MN; Cheng Y; Li Y; Hicklin DJ; Zhu Z; Waltz SE; Hayman MJ; Ludwig DL; Pereira DS
Cancer Res; 2006 Sep; 66(18):9162-70. PubMed ID: 16982759
[TBL] [Abstract][Full Text] [Related]
8. Activation of the RON receptor tyrosine kinase attenuates transforming growth factor-beta1-induced apoptotic death and promotes phenotypic changes in mouse intestinal epithelial cells.
Wang D; Shen Q; Xu XM; Chen YQ; Wang MH
Carcinogenesis; 2005 Jan; 26(1):27-36. PubMed ID: 15447977
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
Camp ER; Yang A; Gray MJ; Fan F; Hamilton SR; Evans DB; Hooper AT; Pereira DS; Hicklin DJ; Ellis LM
Cancer; 2007 Mar; 109(6):1030-9. PubMed ID: 17311308
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.
Ma Q; Zhang K; Yao HP; Zhou YQ; Padhye S; Wang MH
Int J Oncol; 2010 Jun; 36(6):1551-61. PubMed ID: 20428780
[TBL] [Abstract][Full Text] [Related]
11. Identification of the ron gene product as the receptor for the human macrophage stimulating protein.
Wang MH; Ronsin C; Gesnel MC; Coupey L; Skeel A; Leonard EJ; Breathnach R
Science; 1994 Oct; 266(5182):117-9. PubMed ID: 7939629
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of TLR4-induced IκB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein.
Ray M; Yu S; Sharda DR; Wilson CB; Liu Q; Kaushal N; Prabhu KS; Hankey PA
J Immunol; 2010 Dec; 185(12):7309-16. PubMed ID: 21078906
[TBL] [Abstract][Full Text] [Related]
13. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
Castro NE; Lange CA
Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration.
Willett CG; Wang MH; Emanuel RL; Graham SA; Smith DI; Shridhar V; Sugarbaker DJ; Sunday ME
Am J Respir Cell Mol Biol; 1998 Apr; 18(4):489-96. PubMed ID: 9533936
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide.
Morrison AC; Wilson CB; Ray M; Correll PH
J Immunol; 2004 Feb; 172(3):1825-32. PubMed ID: 14734766
[TBL] [Abstract][Full Text] [Related]
16. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma.
Vanderwerff BR; Church KJ; Kawas LH; Harding JW
Cytokine; 2019 Nov; 123():154762. PubMed ID: 31254927
[TBL] [Abstract][Full Text] [Related]
17. RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP.
Gaudino G; Follenzi A; Naldini L; Collesi C; Santoro M; Gallo KA; Godowski PJ; Comoglio PM
EMBO J; 1994 Aug; 13(15):3524-32. PubMed ID: 8062829
[TBL] [Abstract][Full Text] [Related]
18. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
[TBL] [Abstract][Full Text] [Related]
19. The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation.
Angeloni D; Danilkovitch-Miagkova A; Miagkov A; Leonard EJ; Lerman MI
J Biol Chem; 2004 Jan; 279(5):3726-32. PubMed ID: 14597639
[TBL] [Abstract][Full Text] [Related]
20. The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.
Feres KJ; Ischenko I; Hayman MJ
Oncogene; 2009 Jan; 28(2):279-88. PubMed ID: 18836480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
